Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
NCT ID: NCT05729529
Last Updated: 2023-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-01-20
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recent studies suggest the existence of neurological factors as a possible cause of the disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alpha Lipoic Acid for Burning Mouth
NCT00387543
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
NCT06040190
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
NCT06195137
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
NCT02580734
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
NCT05872789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
60 patients with BMS, in two groups: case group with 600 mg/day and placebo as control group; with a follow-up of 2 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lipoic acid gel
Patients were treated with a topic gel of lipoic acid
Lipoid acid gel
Topic lipoid acid gel used with topic oral gel used on tongue
Placebo
Patients treated with a placebo gel control
Placebo
Placebo oral gel used on tongue
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lipoid acid gel
Topic lipoid acid gel used with topic oral gel used on tongue
Placebo
Placebo oral gel used on tongue
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Catania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gaetano Isola
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gaetano Isola
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi di Catania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Policlinico G. Rodolico
Catania, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gaetano Isola, DDS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
121-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.